Literature DB >> 1220709

[Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].

M Benveniste, J Crouzet, J C Homberg, M Lessana, J P Camus, J Hewitt.   

Abstract

The authors present 5 cases of pemphigus induced by D-penicillamine in a series of 180 cases of rheumatoid arthritis treated with this medication. In addition, anti-epidermal intercellular substance antibodies were sought in 40 asymptomatic patients. No antibodies were found in this group. The notion of induced pemphigus seems well established, as is the value of testing for antibodies in the surveillance of D-penicillamine treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1220709

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  10 in total

1.  Penicillamine-induced pemphigus.

Authors:  R A Marsden; H Hill; A G Mowat; M Walshe; R I Vanhegan; T J Ryan
Journal:  Proc R Soc Med       Date:  1977

2.  Pemphigus foliaceus induced by penicillamine.

Authors:  R A Marsden; R I Vanhegan; M Walshe; H Hill; A G Mowat
Journal:  Br Med J       Date:  1976-12-11

Review 3.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

4.  Induced pemphigus.

Authors:  V Ruocco; M Pisani
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Autoantibodies in D-penicillamine treated rheumatoid arthritis.

Authors:  J P Camus; J Crouzet; J F Bach; J C Homberg
Journal:  Agents Actions       Date:  1976-02

6.  Thyroid function and immune profile in rheumatoid arthritis. A controlled study.

Authors:  A P Andonopoulos; V Siambi; M Makri; M Christofidou; C Markou; A G Vagenakis
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

7.  D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?

Authors:  A P Andonopoulos; E Terzis; E Tsibri; C A Papasteriades; T Papapetropoulos
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

8.  D-penicillamine in pregnancy--to ban or not to ban?

Authors:  W Endres
Journal:  Klin Wochenschr       Date:  1981-06-01

Review 9.  Ocular myasthenia gravis after D-penicillamine administration.

Authors:  L J Katz; R L Lesser; J R Merikangas; J P Silverman
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

10.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.